Viemed Healthcare
VMD
149 hedge funds and large institutions have $229M invested in Viemed Healthcare in 2026 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 54 increasing their positions, 40 reducing their positions, and 12 closing their positions.
158% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 12
35% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 40
29% more capital invested
Capital invested by funds: $177M → $229M (+$52M)
13% more funds holding
Funds holding: 132 → 149 (+17)
1.71% more ownership
Funds ownership: 62.69% → 64.4% (+1.7%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$2.99M |
| 2 |
MC
Martin & Co
Knoxville,
Tennessee
|
+$2.27M |
| 3 |
Creative Planning
Overland Park,
Kansas
|
+$1.83M |
| 4 |
HIM
Hillsdale Investment Management
Toronto,
Ontario, Canada
|
+$1.66M |
| 5 |
Two Sigma Investments
New York
|
+$1.26M |
Top Sellers
VMD Hedge Fund Activity: Q1 2026 in Review
149 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Viemed Healthcare (VMD) for Q1 2026, worth a combined $229M — up 29% from $177M a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new VMD positions and 12 closed out — a net gain of 19 holders — while 54 added to existing stakes and 40 trimmed.
The largest buyer was Arrowstreet Capital, adding an estimated $2.99M. The largest seller was Segall Bryant & Hamill, exiting entirely with an estimated $2.15M sold.
- 149 institutional investors held Viemed Healthcare (VMD) as of Q1 2026, up from 132 in Q4 2025.
- Funds reported $229M of Viemed Healthcare stock for Q1 2026, up 29% quarter-over-quarter.
- 31 funds opened new Viemed Healthcare positions in Q1 2026 and 12 closed out, a net change of +19 holders.
- The largest Viemed Healthcare buyer in Q1 2026 was Arrowstreet Capital, an estimated $2.99M added.
- The largest Viemed Healthcare seller in Q1 2026 was Segall Bryant & Hamill, an estimated $2.15M sold.
Based on aggregated 13F filings for Q1 2026.